| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/19/1997 | CN1034080C Preparing method for insulin analogs |
| 02/19/1997 | CN1034073C Process for substituted pyridyl-dihydroxy-heptenoic sodium salt |
| 02/18/1997 | US5604261 Having hydroxyl/alkoxyl group ortho to amide group on phenyl ring; high melatonin receptor affinity |
| 02/18/1997 | US5604257 Useful as an osteogenetic accelerator |
| 02/18/1997 | US5604256 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5604225 Dietetics; obesity |
| 02/18/1997 | US5604203 Analogs of peptide YY and uses thereof |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/13/1997 | WO1997005253A2 Transketolase-related protein |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004778A1 Pyridine compounds, intermediates, processes, compositions, and methods |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004763A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | WO1997004668A2 Two-stage preparation |
| 02/13/1997 | WO1996040128A3 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | DE19529612A1 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate Sulfonyl or sulfinyl derivatives benzoylguanidine |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228178A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | CA2227877A1 Pyridine compounds, intermediates, processes, compositions, and methods |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/12/1997 | EP0757911A1 New galenic formulations containing fenofibrate and their applications |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757682A1 Benzofuran derivatives useful as inhibitors of bone resorption |
| 02/12/1997 | EP0757674A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 02/12/1997 | EP0757669A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | CN1142825A Neuroprotective chroman compounds |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142772A Parathyroid hormone formulation |
| 02/11/1997 | US5602135 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
| 02/11/1997 | US5602133 Treatment of polycystic ovary syndrome |
| 02/11/1997 | US5602122 Method for lowering total serum cholesterol and treating hypercholesterolemia with aminoacetylmercapto derivatives |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601837 Oral pharmaceutical composition comprising small particle size psyllium husk, cholestyramine resin |
| 02/11/1997 | CA1338906C 11 beta-substituted progesterone analogs |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997003985A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 02/06/1997 | WO1997003960A1 NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS [R-(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) |
| 02/06/1997 | WO1997003959A1 Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 02/06/1997 | WO1997003958A1 Form iii crystalline (r-(r*,r*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 02/06/1997 | WO1997003944A1 Aliphatic tricarboxylic acid compounds and their production process |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |
| 02/06/1997 | WO1997003663A1 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF |
| 02/06/1997 | WO1997003653A1 Enterogenin pharmaceutical form |
| 02/06/1997 | DE19528524A1 Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung Calcium-containing phosphate binding agents for intestinal and process for its preparation |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2226871A1 Non-.beta.-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof |
| 02/06/1997 | CA2226761A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 02/06/1997 | CA2224289A1 New protein hmw human mp52s |
| 02/06/1997 | CA2200295A1 Enterogenin pharmaceutical form |
| 02/05/1997 | EP0756602A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| 02/05/1997 | EP0756596A1 Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/05/1997 | EP0708778B1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists |
| 02/05/1997 | EP0666850B1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF |
| 02/05/1997 | EP0573499B1 Process for the phosphorylation of insulin and product produced thereby |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1141921A Chromone derivative |
| 02/05/1997 | CN1141920A Thiophene compound, its preparation method and medicinal composition containing same |
| 02/05/1997 | CN1141798A Shihua drink made from traditional Chinese medicine |
| 02/05/1997 | CN1141767A Medical product containing organic ash content capable of emitting far infrared |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/04/1997 | US5599984 Guanylhydrazones and their use to treat inflammatory conditions |
| 02/04/1997 | US5599975 Cyclised analogues of fatty acid metabolites |
| 02/04/1997 | US5599954 N-substituted-7-amino-5-hydroxy-3-oxoheptanoic acid derivatives and method for producing the same |
| 02/04/1997 | US5599833 Sulfonate and carbamate derivatives of 3-aroylbenzo[B]thiophenes |
| 02/04/1997 | US5599826 Thiazolidinediones and drugs containing them |
| 02/04/1997 | US5599822 Methods for minimizing bone loss |
| 02/04/1997 | US5599810 Furo- and thieno[4,3,2-ef][3]benzazepines useful as alpha adrenergic receptor antagonists |
| 02/04/1997 | US5599388 Acid resistant calcium carbonate composition containing an aluminum salt, uses therefor and processes for its production |
| 02/04/1997 | CA2053820C Method of inhibiting metabolism of cholesterol |
| 02/04/1997 | CA1338895C Diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical composition containing them |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997002834A1 Analogs of parathyroid hormone |
| 01/30/1997 | WO1997002826A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 01/30/1997 | WO1997002819A1 2-[2-(dimethylamino)ethyl]-8,8-dipropyl-2-azaspiro[4.5]decane dimaleate |
| 01/30/1997 | WO1996035805A3 Tripeptidylpeptidase inhibitors |
| 01/30/1997 | WO1996033724A3 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 01/30/1997 | DE19527552A1 Transketolase-verwandtes-Protein Transketolase-related protein |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755919A2 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them |
| 01/29/1997 | EP0755633A1 Two phases preparation |
| 01/29/1997 | EP0755408A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 01/29/1997 | EP0755396A1 Stable aqueous folinate solution |
| 01/29/1997 | EP0755394A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds |
| 01/29/1997 | EP0755384A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives |
| 01/29/1997 | EP0755258A1 Methods of treating disease using sertoli cells and allografts or xenografts |
| 01/29/1997 | EP0698012B1 Use of deoxygalactonojirimycin derivatives for inhibiting glycolipid synthesis |
| 01/29/1997 | EP0675878B1 Novel vitamin d analogues |